SRPT vs TENX · rev $1.13B vs P/E 3.4, $24.1M cap
Sarepta Therapeutics Inc (SRPT) versus Tenax Therapeutics Inc (TENX) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Tenax Therapeutics Inc (TENX) is a biotechnology company listed on US.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Latest reported TENX revenue for 2026-06-30 was $0. Net income was -$33.5M. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
SRPT currently screens at market cap $2.34B. TENX currently screens at market cap $24.1M and trailing P/E 3.4.
Not investment advice. Open the SRPT and TENX stock pages for the full models.
Not investment advice.